GCP
OME

GSA Capital Partners’s Omega Protein OME Stock Holding History

GSA Capital Partners’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,296
Closed -$206K – 2114
2017
Q1 		$206K Sell
10,296
-7,044
-41% -$164K 0.01% 1562
2016
Q4 		$434K Sell
17,340
-14,233
-45% -$336K 0.03% 1094
2016
Q3 		$738K Sell
31,573
-70,185
-69% -$1.65M 0.04% 815
2016
Q2 		$2.03M Buy
101,758
+70,458
+225% +$1.32M 0.11% 236
2016
Q1 		$530K Sell
31,300
-2,811
-8% -$57.6K 0.03% 985
2015
Q4 		$757K Buy
34,111
+20,688
+154% +$431K 0.04% 900
2015
Q3 		$228K Buy
+13,423
New +$209K 0.01% 1514
2015
Q2 		– Sell
-38,800
Closed -$531K – 2324
2015
Q1 		$531K Buy
+38,800
New +$448K 0.02% 1346
2013
Q3 		– Sell
-25,582
Closed -$230K – 1724
2013
Q2 		$230K Buy
+25,582
New +$258K 0.03% 1019

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSA Capital Partners's OME Position: Q2 2017 in Review

GSA Capital Partners sold out of Omega Protein (OME) in Q2 2017, closing a stake of 10,296 shares — an estimated $206K sold.

GSA Capital Partners first reported a position in OME in Q2 2013 and held it in 9 quarters. The position peaked at $2.03M in Q2 2016. 140 funds tracked by Wall St. Rank hold OME as of Q2 2017.

  • GSA Capital Partners reported no remaining Omega Protein position as of Q2 2017 after selling out during the quarter.
  • GSA Capital Partners sold 10,296 Omega Protein shares in Q2 2017, an estimated $206K.
  • GSA Capital Partners first reported a position in Omega Protein in Q2 2013 and held it in 9 quarters.
  • GSA Capital Partners's Omega Protein position peaked at $2.03M in Q2 2016.
  • 140 funds tracked by Wall St. Rank held Omega Protein as of Q2 2017.

Based on GSA Capital Partners's 13F filing for Q2 2017, filed 11 Aug 2017.